logo

AMBALALSA vs ZOTA: Stock Comparison

AMBALALSA vs ZOTA HEALTH CAREUpdated 20 Aug 26, 4:08 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. AMBALALSA shows a higher ROE, a higher ROCE and a higher net margin, while ZOTA HEALTH CARE shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMBALALSA leads 6; ZOTA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMBALALSAZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹303 Cr
₹4,714 Cr
P/E RatioZOTA has the lower reading
27.1x
0x ✓
P/B RatioAMBALALSA has the lower reading
2.22x ✓
6.8x
EPSAMBALALSA has the higher reading
₹0.52 ✓
₹-12.58
Book ValueContext only
₹20.67
₹201.01
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹4,714 Cr vs ₹303 Cr
P/E Ratio
ZOTA has a lower P/E
0x vs 27.1x
P/B Ratio
AMBALALSA has a lower P/B
2.22x vs 6.8x
EPS
AMBALALSA has higher earnings per share
₹0.52 vs ₹-12.58
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
0% vs -33.48%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
0% vs -38.84%
ROE
AMBALALSA has a higher ROE
18.48% vs -10.64%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMBALALSAZOTA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricAMBALALSAZOTA
Live Price₹47.74₹1,359.9
Day Change3.07%-3.51%
Volume2.46 L44,643
52-Week High₹49.98₹1,740
52-Week Low₹30.15₹1,022
Distance from 52W High-4.48%-21.84%

Valuation

MetricAMBALALSAZOTA
Market Cap₹303 Cr₹4,714 Cr
P/E Ratio27.1x0x
P/B Ratio2.22x6.8x
EPS₹0.52₹-12.58
Book Value₹20.67₹201.01
Dividend Yield0%0%

Growth

MetricAMBALALSAZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-33.48%0%
Qtr Profit Growth-38.84%0%

Profitability & Leverage

MetricAMBALALSAZOTA
ROE18.48%-10.64%
ROCE14.73%-8.71%
Net Margin8.8%-13.98%
Operating Margin262.56%-11.6%
Debt to Equity0.19x0.04x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMBALALSAZOTA
Promoter Holding31.36%49.38%
FII Holding0%7.92%▼ 0.29 pp
DII Holding0.01%6.75%▲ 0.35 pp
Public Holding68.64%35.96%▼ 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMBALALSA and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.